FORZINITY (ELAMIPRETIDE HCI) INJECTION Trademark
Trademark Overview
On Monday, March 17, 2025, a trademark application was filed for FORZINITY (ELAMIPRETIDE HCI) INJECTION with the United States Patent and Trademark Office. The USPTO has given the FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark a serial number of 99087371. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 17, 2025. This trademark is owned by STEALTH BIOTHERAPEUTICS INC.. The FORZINITY (ELAMIPRETIDE HCI) INJECTION trademark is filed in the Pharmaceutical Products category with the following description:
Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities.
General Information
| Serial Number | 99087371 |
| Word Mark | FORZINITY (ELAMIPRETIDE HCI) INJECTION |
| Filing Date | Monday, March 17, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Monday, March 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 0 - NOT AVAILABLE |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording “FORZINITY” directly stacked above the wording “(elamipretide HCI) Injection.” To the right of the wording is six geometric shapes, all in different sizes. |
| Goods and Services | Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities. |
| NOT AVAILABLE | No claim is made to the exclusive right to use (Elamipretide HCI) injection, apart from the mark as shown. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 17, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | STEALTH BIOTHERAPEUTICS INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Needham, MA 02494 |
Trademark Events
| Event Date | Event Description |
| Monday, March 17, 2025 | NEW APPLICATION ENTERED |
| Monday, March 17, 2025 | APPLICATION FILING RECEIPT MAILED |
